Searchable abstracts of presentations at key conferences in endocrinology

ea0015p283 | Reproduction | SFEBES2008

Rimonabant is more effective in patients with metabolic syndrome compared to patients without metabolic syndrome in polycystic ovary syndrome

Sathyapalan Thozhukat , Chow Li Wei , Kilpatrick Eric S , Coady Anne-Marie , Atkin Stephen L

Context: Rimonabant has been found to reduce weight and improve the metabolic profile in patients with metabolic syndrome as well as PCOS.Objective: To compare the effects of metformin and rimonabant in patients with PCOS with and without metabolic syndrome according to ATP III criteria.Design: A randomised open labelled parallel study comparing the effects on rimonabant and metformin in patients with PCOS.Su...